Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood

Wound Repair and Regeneration

Volumn 18, Issue 5, 2010, Pages 506-513

  Luo, Gaoxing ^a   Cheng, Wenguang ^a   He, Weifeng ^a   Wang, Xiaojuan ^a   Tan, Jiangling ^a   Fitzgerald, Mark ^b   Li, Xianchang ^c   Wu, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ALFRED HOSPITAL   (Australia)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED BALB C; SKIN; TREATMENT OUTCOME; WOUND HEALING; WOUNDS AND INJURIES;

EID: 77956633464     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2010.00616.x     Document Type: Article

References (39)

1. Atiyeh BS, Gunn W, Hayek SN. State of the art in burn treatment. World J Surg 2005 29: 131 148.
2. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005 366: 1736 1743.
3. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997 276: 75 81.
4. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999 341: 738 746.
5. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfect: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002 99: 8932 8937.
6. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004 363: 1439 1441.
7. Gordon MY. Stem cells for regenerative medicine - biological attributes and clinical application. Exp Hematol 2008 36: 726 732.
8. Weedell KS. New paths to pluripotent stem cells. Curr Stem Cell Res Ther 2008 3: 151 162.
9. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008 8: 726 736.
10. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 2006 24: 1294 1301.
11. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A. Biology of the stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007 25: 319 331.
12. MacKenzie TC, Flake AW. Human mesenchymal stem cells: insights from a surrogate in vivo assay system. Cells Tissues Organs 2002 171: 90 5.
13. Le Ricousse-Roussanne S, Barateau V, Contreres JO, Boval B, Kraus-Berthier L, Tobelem G. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 2004 62: 176 184.
14. Jager M, Sager M, Knipper A, Degistirici O, Fischer J, Kogler G, Wernet P, Krauspe R. In vivo and in vitro bone regeneration from cord blood derived mesenchymal stem cells. Orthopade 2004 33: 1361 1372.
15. Gang EJ, Jeong JA, Hong SH, Hwang SH, Kim SW, Yang IH, Ahn C, Han H, Kim H. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 2004 22: 617 624.
16. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002 418: 41 9.
17. Steck E, Bertram H, Abel R, Chen B, Winter A, Richter W. Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem Cells 2005 23: 403 411.
18. Gronthos S, Brahim J, Li W, Fisher LW, Cherman N, Boyde A, DenBesten P, Robey PG, Shi S. Stem cell properties of human dental pulp stem cells. J Dent Res 2002 81: 531 535.
19. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004 103: 1669 1675.
20. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002 13: 4279 4295.
21. Stenderup K, Justuesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003 33: 919 926.
22. Mareschi K, Biastin L, Piacibello W, Biasin E, Piacibello W, Aglietta M, Madon E, Faioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 2001 86: 1099 1100.
23. Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, Hwang SM Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006 24: 679 685.
24. Wild A, Jager M, Lensing-Hoehn S, Werne A, Krauspe R. Influence of different culture solutions on osteoblastic differentiation in cord blood and bone marrow derived progenitor cells. Biomed Tech 2003 48: 241 244.
25. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999 284: 143 147.
26. Dolbeare F. Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part I: historical perspectives, histochemical methods and cell kinetics. Histochem J 1995 27: 339 369.
27. McGinley JN, Knott KK, Thompson HJ. Effect of fixation and epitope retrieval on BrdU indices in mammary carcinomas. J Histochem Cytochem 2000 48: 355 362.
28. Shimada A, Shibata T, Komatsu K, Nifuji A. Improved methods for immunohisto-chemical detection of BrdU in hard tissue. J Immmunol Method 2008 339: 11 6.
29. Koch TG, Heerkens T, Thomsen PD, Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 2007 7: 26 34.
30. Gu YC, Rao MS, Vemuri MC. Human cord blood stem cell applications in cell therapy. J Stem Cells 2009 4: 95 103.
31. Bieback K, Kern S, Kluter H. Critical parameters in the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004 24: 625 634.
32. Secco M, Zucconi E, Vieira NM, Fogaça LL, Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR, Zatz M. Multipotent stem cells from umbilical cord: cord is richer than blood. Stem Cells 2008 26: 146 150.
33. Wu YJ, Chen LW, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differention and angiogenesis. Stem Cells 2007 25: 2648 2659.
34. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008 180: 2581 2587.
35. Li H, Fu X, Ouyang Y, Cai C, Wang J, Sun T. Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res 2006 326: 725 736.
36. Oh JY, Kim MK, Shin MS, Lee HJ, Ko JH, Wee WR, Lee JH. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells 2008 26: 1047 1055.
37. Dezawa M. Systematic neuronal and muscle induction systems in bone marrow stromal cells: the potential for tissue reconstruction in neurodegenerative and muscle degenerative diseases. Med Mol Morphol 2008 41: 14 9.
38. Song H, Song BW, Cha MJ, Choi IG, Hwang KC. Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin Biol Ther 2010 10: 309 319.
39. Lee PH, Park HJ. Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy. J Clin Neurol 2009 5: 1 10.